G1 Therapeutics (GTHX) Debt/EBITDA US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
Debt/EBITDA | 2.01 | 1.87 | 0.97 | 0.45 | 0.64 | 0.85 | |||
Changes by years, y/y, % | -51% | -7% | -48% | -53% | +41% | -31.1% |
G1 Therapeutics. Debt/EBITDA
G1 Therapeutics. Debt/EBITDA, changes, %
G1 Therapeutics (GTHX) Debt/EBITDA US GAAP (quarter values) |
||||||||
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
Debt/EBITDA | 0.99 | 0.77 | 1.54 | 0.68 | 0.85 | 0.85 | ||
Changes by years, y/y, % | +60% | +102% | +443% | +50% | -13% | |||
Changes by quarters, q/q, % | +117% | -22% | +101% | -56% | +26% |